explore -WSS

explore

author：hotspot 2025-09-30 17:02:39 - browse：1

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Dozens dead from Maui wildfires: What we know about the victims

explore

knowledge

WSS

Biogen nominates mother of director’s child to replace him on board

Dozens dead from Maui wildfires: What we know about the victims

Timeline: Key moments in fight for gay rights

After Optum profits sink, UnitedHealth makes changes

Patients, digital health players weigh in on FTC's data privacy plan

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

focus

explore

hotspot

Continuity nursing helped my family in our darkest PICU moments

Senators push IRS to launch nonprofit hospital probe

Cancer drug shortages should be causing more outrage

Bispecific antibodies are next new thing in cancer immunotherapy

Hepatitis C has a cure — but many Americans still lack access to it

Reanimated hearts work just as well for transplants, study finds

Trump demands the U.S. pay no more for drugs than other countries … again

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Heart attack and stroke risk calculators need revising

Eli Lilly’s Mounjaro succeeds in second weight

hotspot

After Optum profits sink, UnitedHealth makes changes

Idaho college killings prosecutors challenge defense's grand jury claims

A public health expert passes on football's full body collisions for youths

Timeline: Key moments in fight for gay rights

BMS, looking to build heart drug business, turns to AI for diagnosis

Health AI: on the border between health care and tech

explore

knowledge

knowledge

explore